<DOC>
	<DOCNO>NCT00418366</DOCNO>
	<brief_summary>A study evaluate effect kidney disease , mild severe disease , diabetes medication</brief_summary>
	<brief_title>A Study Effect Kidney Disease Diabetes Medication ( 0431-008 )</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Inclusion Criteria : Male nonpregnant female clinical diagnosis renal insufficiency mild , moderate , severe end stage renal disease hemodialysis A body mass index le 40 kg per meter square ( body weight kg divide height meter square ) Smokes le 10 cigarettes/day Exclusion Criteria : Patients uncontrolled diabetes uncontrolled congestive heart failure Patient abnormal prestudy laboratory measurement include serum potassium white blood count Patient systolic blood pressure 100 mm Hg 180 mm Hg Patient diastolic blood pressure le 50 mm Hg systolic 100 mmHg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Mild , moderate , severe renal insufficiency</keyword>
	<keyword>End stage renal disease</keyword>
</DOC>